Quadrant Capital Group LLC Novavax Inc Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Novavax Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 1,810 shares of NVAX stock, worth $15,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,810

Previous 2,116 14.46%

Holding current value

$15,330

Previous $26,000 15.38%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$10.71 - $17.11 $3,277 - $5,235	-306 Reduced 14.46%	1,810 $22,000
Q2 2024 Aug 12, 2024	BUY	$3.89 - $20.97 $4,481 - $24,157	1,152 Added 119.5%	2,116 $26,000
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $1,748 - $2,799	465 Added 93.19%	964 $4,000
Q4 2023 Feb 08, 2024	SELL	$4.8 - $7.67 $15,993 - $25,556	-3,332 Reduced 86.97%	499 $2,000
Q3 2023 Nov 14, 2023	SELL	$6.81 - $9.74 $3,500 - $5,006	-514 Reduced 11.83%	3,831 $27,000
Q2 2023 Aug 09, 2023	BUY	$6.67 - $9.52 $4,815 - $6,873	722 Added 19.93%	4,345 $32,000
Q1 2023 May 11, 2023	BUY	$5.76 - $12.48 $17,412 - $37,727	3,023 Added 503.83%	3,623 $25,000
Q4 2022 Feb 10, 2023	BUY	$8.86 - $25.04 $2,994 - $8,463	338 Added 129.01%	600 $6,000
Q3 2022 Nov 10, 2022	SELL	$18.2 - $76.12 $1,583 - $6,622	-87 Reduced 24.93%	262 $5,000
Q2 2022 Aug 09, 2022	BUY	$36.28 - $75.29 $3,156 - $6,550	87 Added 33.21%	349 $18,000
Q1 2022 May 06, 2022	BUY	$69.73 - $142.9 $6,415 - $13,146	92 Added 54.12%	262 $19,000
Q4 2021 Feb 01, 2022	SELL	$134.56 - $217.97 $7,535 - $12,206	-56 Reduced 24.78%	170 $24,000
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $10,668 - $16,234	60 Added 36.14%	226 $47,000
Q2 2021 Aug 09, 2021	BUY	$121.0 - $257.67 $7,381 - $15,717	61 Added 58.1%	166 $35,000
Q1 2021 May 12, 2021	BUY	$112.98 - $319.93 $3,050 - $8,638	27 Added 34.62%	105 $19,000
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $944 - $1,674	-12 Reduced 13.33%	78 $9,000
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $953 - $2,142	12 Added 15.38%	90 $10,000
Q2 2020 Aug 13, 2020	BUY	$13.86 - $83.61 $1,081 - $6,521	78 New	78 $7,000

Others Institutions Holding NVAX

# of Institutions

292

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Novavax Inc Transaction History